Recurrent Ovarian Carcinoma Recruiting Phase 2 Trials for Human interleukin-2 (DB14865)

IndicationStatusPhase
DBCOND0030000 (Recurrent Ovarian Carcinoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs